Get the Stockscreener App
0.00
100.00%
-0.3207
InVivo Therapeutics Holdings Corp Stock (NVIV) Forecast
The InVivo Therapeutics Holdings Corp (NVIV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $76.81, representing a + increase from the current price of $0.00. The highest analyst price target is $134.55, and the lowest is $19.07.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVIV Price Target
Average 416.59
(+ Upside)
Is InVivo Therapeutics Holdings Corp (NVIV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.54 | Buy |
| STOCH(9,6) | 28.54 | Neutral |
| STOCHRSI(14) | 33.74 | Neutral |
| MACD(12,26) | -0.1159 | Sell |
| ADX(14) | 26.47 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -187.51 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4034
Sell
|
0.3986
Sell
|
| MA20 |
0.5433
Sell
|
0.5021
Sell
|
| MA50 |
0.6729
Sell
|
0.6418
Sell
|
| MA100 |
0.8048
Sell
|
0.7906
Sell
|
| MA200 |
1.0431
Sell
|
1.0397
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NVIV could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NVIV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.54 indicates that NVIV is oversold. This indicates that NVIV price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 28.54 indicates that NVIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.74 indicates that NVIV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.47 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -187.51 indicates that NVIV is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NVIV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about InVivo Therapeutics Holdings Corp financial reports and earnings history, InVivo Therapeutics Holdings Corp (NVIV) stock could reach $1,079.83 by 2030, $571.18 by 2040 and $2,262.70 by 2050. See the projected annual prices until 2050 of the InVivo Therapeutics Holdings Corp stock below:
- InVivo Therapeutics Holdings Corp (NVIV) is expected to reach an average price of $86.00 in 2035, with a high prediction of $116.79 and a low estimate of $86.19. This indicates an $ rise from the last recorded price of $0.00.
- InVivo Therapeutics Holdings Corp (NVIV) stock is projected to chart a bullish course in 2040, with an average price target of $525.73, representing an $ surge from its current level. The forecast ranges from a conservative $525.74 to a sky-high $571.18.
- Our analysts predict InVivo Therapeutics Holdings Corp (NVIV) to jump by 2045, soaring from $1,224.55 to an average price of $1,224.29, potentially reaching $1,278.94. While $1,224.55 is the low estimate, the potential upside is significant.
- InVivo Therapeutics Holdings Corp (NVIV) stock is expected to climb by 2050, reaching an average of $2,189.33, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $2,262.70 and $2,190.34, respectively, highlighting the market's uncertainty.
InVivo Therapeutics Holdings Corp Stock (NVIV) Year by Year Forecast
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2024
Our forecast for NVIV stock price in 2024 now indicates an average price target of $306.87 with a high forecast of $611.14 and a low forecast of $2.6105. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $116.30 | $19.07 | $134.55 | + |
| June, 2024 | $198.26 | $149.91 | $93.53 | + |
| July, 2024 | $441.33 | $503.57 | $441.33 | + |
| August, 2024 | $518.80 | $553.11 | $502.43 | + |
| September, 2024 | $533.95 | $518.66 | $545.26 | + |
| October, 2024 | $591.38 | $529.99 | $542.33 | + |
| November, 2024 | $602.02 | $596.95 | $585.70 | + |
| December, 2024 | $616.84 | $628.03 | $611.14 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2025
InVivo Therapeutics Holdings Corp Stock (NVIV) is expected to reach an average price of $768.96 in 2025, with a high prediction of $830.81 and a low estimate of $707.11. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $802.70 | $812.08 | $814.10 | + |
| February, 2025 | $733.54 | $778.82 | $792.44 | + |
| March, 2025 | $740.36 | $714.52 | $710.36 | + |
| April, 2025 | $828.58 | $721.33 | $716.75 | + |
| May, 2025 | $817.04 | $824.79 | $830.81 | + |
| June, 2025 | $803.36 | $806.11 | $804.15 | + |
| July, 2025 | $785.32 | $790.07 | $796.23 | + |
| August, 2025 | $768.03 | $768.53 | $781.69 | + |
| September, 2025 | $748.11 | $754.36 | $761.90 | + |
| October, 2025 | $735.32 | $737.32 | $736.97 | + |
| November, 2025 | $727.03 | $727.78 | $730.93 | + |
| December, 2025 | $703.86 | $707.11 | $718.15 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2026
The predicted value for InVivo Therapeutics Holdings Corp (NVIV) in 2026 is set at an average of $614.06. Estimates vary from a peak of $707.82 to a trough of $520.30, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $709.80 | $698.59 | $707.82 | + |
| February, 2026 | $693.49 | $694.03 | $705.43 | + |
| March, 2026 | $671.60 | $673.84 | $688.27 | + |
| April, 2026 | $637.81 | $649.44 | $662.47 | + |
| May, 2026 | $619.02 | $619.02 | $629.17 | + |
| June, 2026 | $612.35 | $613.97 | $618.25 | + |
| July, 2026 | $603.81 | $603.65 | $608.71 | + |
| August, 2026 | $585.14 | $586.64 | $597.93 | + |
| September, 2026 | $568.42 | $569.85 | $580.25 | + |
| October, 2026 | $555.03 | $555.56 | $564.24 | + |
| November, 2026 | $537.41 | $537.56 | $546.29 | + |
| December, 2026 | $519.81 | $520.30 | $528.27 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for InVivo Therapeutics Holdings Corp (NVIV) is $422.44, with a high forecast of $513.71 and a low forecast of $331.18. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $503.83 | $505.29 | $513.71 | + |
| February, 2027 | $490.72 | $490.74 | $499.86 | + |
| March, 2027 | $472.47 | $474.09 | $485.38 | + |
| April, 2027 | $456.88 | $457.80 | $467.14 | + |
| May, 2027 | $439.75 | $440.35 | $452.42 | + |
| June, 2027 | $427.43 | $427.90 | $434.04 | + |
| July, 2027 | $412.97 | $413.05 | $423.15 | + |
| August, 2027 | $392.32 | $392.48 | $408.41 | + |
| September, 2027 | $380.45 | $380.63 | $388.00 | + |
| October, 2027 | $364.94 | $365.45 | $375.85 | + |
| November, 2027 | $346.22 | $346.75 | $360.39 | + |
| December, 2027 | $330.94 | $331.18 | $341.69 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2028
In 2028, InVivo Therapeutics Holdings Corp (NVIV) is projected to reach an average price of $229.08, with a high projection of $326.58 and a low estimate of $131.59. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $307.80 | $307.89 | $326.58 | + |
| February, 2028 | $293.95 | $294.69 | $303.76 | + |
| March, 2028 | $280.28 | $280.31 | $289.18 | + |
| April, 2028 | $266.47 | $266.54 | $276.74 | + |
| May, 2028 | $247.36 | $247.40 | $262.35 | + |
| June, 2028 | $231.80 | $232.09 | $243.25 | + |
| July, 2028 | $212.20 | $212.22 | $227.46 | + |
| August, 2028 | $196.80 | $197.00 | $208.07 | + |
| September, 2028 | $182.34 | $182.35 | $192.82 | + |
| October, 2028 | $162.77 | $162.98 | $178.34 | + |
| November, 2028 | $147.04 | $147.05 | $158.48 | + |
| December, 2028 | $131.57 | $131.59 | $143.15 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2029
The 2029 price forecast for InVivo Therapeutics Holdings Corp Stock (NVIV) is $543.49 on average, with a high prediction of $1,083.06 and a low estimate of $3.9194. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $112.15 | $112.15 | $127.60 | + |
| February, 2029 | $96.48 | $96.53 | $108.15 | + |
| March, 2029 | $81.08 | $81.20 | $92.57 | + |
| April, 2029 | $61.73 | $61.78 | $77.16 | + |
| May, 2029 | $46.35 | $46.48 | $57.79 | + |
| June, 2029 | $31.06 | $31.13 | $42.45 | + |
| July, 2029 | $11.64 | $11.75 | $27.16 | + |
| August, 2029 | $1,153.26 | $3.9194 | $1,040.76 | + |
| September, 2029 | $1,122.18 | $1,137.72 | $1,054.68 | + |
| October, 2029 | $1,135.83 | $1,054.14 | $1,061.10 | + |
| November, 2029 | $998.85 | $1,042.43 | $1,083.06 | + |
| December, 2029 | $998.41 | $1,021.18 | $961.45 | + |
InVivo Therapeutics Holdings Corp Stock (NVIV) Price Forecast for 2030
InVivo Therapeutics Holdings Corp Stock (NVIV) is expected to reach an average price of $1,417.67 in 2030, with a high forecast of $1,747.20 and a low forecast of $1,088.14. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1,154.83 | $1,088.14 | $1,079.83 | + |
| February, 2030 | $1,522.75 | $1,270.81 | $1,221.25 | + |
| March, 2030 | $1,467.67 | $1,533.79 | $1,471.70 | + |
| April, 2030 | $1,523.92 | $1,525.57 | $1,517.11 | + |
| May, 2030 | $1,525.32 | $1,547.73 | $1,540.51 | + |
| June, 2030 | $1,567.21 | $1,516.45 | $1,518.16 | + |
| July, 2030 | $1,593.69 | $1,568.89 | $1,557.64 | + |
| August, 2030 | $1,557.71 | $1,572.78 | $1,559.78 | + |
| September, 2030 | $1,730.39 | $1,731.66 | $1,747.20 | + |
| October, 2030 | $1,596.18 | $1,641.56 | $1,694.42 | + |
| November, 2030 | $1,630.73 | $1,616.54 | $1,600.73 | + |
| December, 2030 | $1,707.28 | $1,607.81 | $1,690.63 | + |
6.15%
1.42%
Cap:
|
Volume (24h):